Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: A systematic review and meta-analysis

Vaccine

Volumn 30, Issue 38, 2012, Pages 5595-5602

  Aalaei Andabili, Seyed Hossein ^a   Alavian, Seyed Moayed ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis B; Meta analysis; Regulatory T cells; Treatment

Indexed keywords

ALPHA INTERFERON; TRANSCRIPTION FACTOR FOXP3;

CANCER RISK; CD8+ T LYMPHOCYTE; CELL ACTIVITY; DISEASE COURSE; HEPATITIS B; HUMAN; IMMUNE RESPONSE; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

DISEASE PROGRESSION; HEPATITIS B; HUMANS; IMMUNOSUPPRESSION; PROGNOSIS; T-LYMPHOCYTES, REGULATORY;

EID: 84864770681     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.06.063     Document Type: Review

References (61)

1. Alavian S.M., Hajarizadeh B., Ahmadzad-Asl M., Kabir A., Bagheri-Lankarani K. Hepatitis B virus infection in Iran: a systematic review. Hepat Mon 2008, 8(4):14.
2. Matthews G.V., Nelson M.R. The management of chronic hepatitis B infection. Int J STD AIDS 2001, 12(June (6)):353-357.
3. Guidotti L.G., Chisari F.V. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 2006, 1:23-61.
4. Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 2004, 127(November (5 Suppl.)):S56-S61.
5. Schwartz R.H. T cell anergy. Annu Rev Immunol 2003, 21:305-334.
6. Chen M., Sallberg M., Hughes J., Jones J., Guidotti L.G., Chisari F.V., et al. Immune tolerance split between hepatitis B virus precore and core proteins. J Virol 2005, 79(March (5)):3016-3027.
7. Bertoletti A., Naoumov N.V. Translation of immunological knowledge into better treatments of chronic hepatitis B. J Hepatol 2003, 39(July (1)):115-124.
8. Mills K.H., McGuirk P. Antigen-specific regulatory T cells - their induction and role in infection. Semin Immunol 2004, 16(April (2)):107-117.
9. Stoop J.N., van der Molen R.G., Baan C.C., van der Laan L.J., Kuipers E.J., Kusters J.G., et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005, 41(April (4)):771-778.
10. Xu D., Fu J., Jin L., Zhang H., Zhou C., Zou Z., et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006, 177(July (1)):739-747.
11. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002, 2(June (6)):389-400.
12. Shevach E.M., McHugh R.S., Piccirillo C.A., Thornton A.M. Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev 2001, 182(August):58-67.
13. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531-562.
14. Rehermann B., Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005, 5(March (3)):215-229.
15. Billerbeck E., Bottler T., Regulatory T.R. T cells in viral hepatitis. World J Gastroenterol 2007, 13(September (36)):4858-4864.
16. Feng I.C., Koay L.B., Sheu M.J., Kuo H.T., Sun C.S., Lee C., et al. HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection. J Biomed Sci 2007, 14(January (1)):43-57.
17. Shevach E.M., McHugh R.S., Piccirillo C.A., Thornton A.M. Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev [review] 2001, 182(August):58-67.
18. Khazaie K., von Boehmer H. The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer. Semin Cancer Biol 2006, 16(April (2)):124-136.
19. Ayers C.L., Firan M., Pillai V., Lee W.M., Karandikar N.J. Viral interactions with B-cells contribute to increased regulatory T-cells during chronic HCV infection. Viral Immunol 2011, 24(April (2)):119-129.
20. Longhi M.S., Ma Y., Bogdanos D.P., Cheeseman P., Mieli-Vergani G., Vergani D. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 2004, 41(July (1)):31-37.
21. Zhang H.H., Mei M.H., Fei R., Liu F., Wang J.H., Liao W.J., et al. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses. J Viral Hepat 2010, 17(Suppl. 1):10.
22. Yang G., Liu A., Xie Q., Guo T.B., Wan B., Zhou B., et al. Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Int Immunol 2007, 19(February (2)):133-140.
23. Franzese O., Kennedy P.T., Gehring A.J., Gotto J., Williams R., Maini M.K., et al. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol [Research Support, Non-U.S. Gov't] 2005, 79(March (6)):3322-3328.
24. Glynn L. EBLIP Critical Appraisal Checklist. Available from: Visited at February 2011. http://wwwnihsie/pdf/EBL%20Critical%20Appraisal%20Checklistpdf.
25. Rucker G., Schwarzer G., Carpenter J.R., Schumacher M. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol 2008, 8:79.
26. Aalaei-Andabili S.H., Alavian S.M. High-quality meta-analyses are required for development of evidence in medicine. J Infect Dis 2012, 205(May (9)):1472.
27. Casares N., Gil-Guerrero L., Melero I., Dubrot J., Lasarte J.J. The many faces of regulatory T cells. Inmunología 2007, 26(1):13.
28. Waris G., Siddiqui A. Regulatory mechanisms of viral hepatitis B and C. J Biosci 2003, 28(April (3)):311-321.
29. Chang J.J., Thompson A.J., Visvanathan K., Kent S.J., Cameron P.U., Wightman F., et al. The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection. Hepatology 2007, 46(November (5)):1332-1340.
30. Sprengers D., Stoop J.N., Binda R.S., Kusters J.G., Haagmans B.L., Carotenuto P., et al. Induction of regulatory T-cells and interleukin-10-producing cells in non-responders to pegylated interferon-alpha therapy for chronic hepatitis B. Antivir Ther 2007, 12(7):1087-1096.
31. Tsal S.L., Wang S.L., Feng I.C., Kuo H.T., Koay L.B., Sheu M.J., et al. Acute exacerbations of chronic Hepatitis B are accompanied by decline of core antigen-specific regulatory T-cell frequencies: implications for successful anti-HBV treatments. Hepat Mon 2007, 7(4):18.
32. Stoop J.N., van der Molen R.G., Kuipers E.J., Kusters J.G., Janssen H.L. Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B. Virology 2007, 361(April (1)):141-148.
33. Kondo Y., Kobayashi K., Ueno Y., Shiina M., Niitsuma H., Kanno N., et al. Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B. World J Gastroenterol 2006, 12(July (27)):4310-4317.
34. Boettler T., Spangenberg H.C., Neumann-Haefelin C., Panther E., Urbani S., Ferrari C., et al. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005, 79(June (12)):7860-7867.
35. Miyaaki H., Zhou H., Ichikawa T., Nakao K., Shibata H., Takeshita S., et al. Study of liver-targeted regulatory T cells in hepatitis B and C virus in chronically infected patients. Liver Int 2009, 29(May (5)):702-707.
36. Stoop J.N., Claassen M.A., Woltman A.M., Binda R.S., Kuipers E.J., Janssen H.L., et al. Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients. Clin Immunol 2008, 129(December (3)):419-427.
37. Sakaki M., Hiroishi K., Baba T., Ito T., Hirayama Y., Saito K., et al. Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis. Hepatol Res 2008, 38(April (4)):354-361.
38. Barboza L., Salmen S., Goncalves L., Colmenares M., Peterson D., Montes H., et al. Antigen-induced regulatory T cells in HBV chronically infected patients. Virology 2007, 368(November (1)):41-49.
39. Zhang W., Sharma R., Ju S.T., He X.S., Tao Y., Tsuneyama K., et al. Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis. Hepatology 2009, 49(February (2)):545-552.
40. Fu J., Xu D., Liu Z., Shi M., Zhao P., Fu B., et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007, 132(June (7)):2328-2339.
41. Xu H., Jiang Y.F., Li W.Y., Niu J.Q. Expression levels of CD4∼+CD25∼+ regulatory T cells in peripheral blood of patients with chronic hepatitis B and clinical significance. J Jilin Univ 2008, 2(44). Abstract.
42. Franzese O., Kennedy P.T., Gehring A.J., Gotto J., Williams R., Maini M.K., et al. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 2005, 79(March (6)):3322-3328.
43. Zhang H.H., Fei R., Mei M.H., Liao W.J., Wang X.Y., Cong X., et al. The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients. Zhonghua Gan Zang Bing Za Zhi 2007, 15(April (4)):266-272.
44. Hong J., Gong Z.J. Human plasmacytoid dendritic cells from patients with chronic hepatitis B virus infection induce the generation of a higher proportion of CD4(+) and CD25(+) regulatory T cells compared with healthy patients. Hepatol Res 2008, 38(April (4)):362-373.
45. Zhang H.H., Guo F., Fei R., Ma H., Cong X., Wei L., et al. Inhibition of CD4+ CD25+ regulatory T cells in chronic hepatitis B patients. Zhonghua Yi Xue Za Zhi 2008, 88(February (8)):511-515.
46. Peng G., Li S., Wu W., Sun Z., Chen Y., Chen Z. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology 2008, 123(January (1)):57-65.
47. Fu J.L., Xu D.P., Zhao P., Chen L.M., Zhang H., Zhou C.B., et al. The characterization of regulatory T cells in peripheral blood of HBV-infected patients. Zhonghua Yi Xue Za Zhi 2006, 86(June (22)):1522-1525.
48. Lin C.Y., Tsai M.C., Huang C.T., Hsu C.W., Tseng S.C., Tsai I.F., et al. Liver injury is associated with enhanced regulatory T-cell activity in patients with chronic hepatitis B. J Viral Hepat 2007, 14(July (7)):503-511.
49. Stoop J.N., Woltman A.M., Biesta P.J., Kusters J.G., Kuipers E.J., Janssen H.L., et al. Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response. Hepatology 2007, 46(September (3)):699-705.
50. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001, 27(January (1)):68-73.
51. Yagi H., Nomura T., Nakamura K., Yamazaki S., Kitawaki T., Hori S., et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004, 16(November (11)):1643-1656.
52. Belkaid Y., Rouse B.T. Natural regulatory T cells in infectious disease. Nat Immunol 2005, 6(April (4)):353-360.
53. van der Molen R.G., Sprengers D., Binda R.S., de Jong E.C., Niesters H.G., Kusters J.G., et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004, 40(September (3)):738-746.
54. Misra N., Bayry J., Lacroix-Desmazes S., Kazatchkine M.D., Kaveri S.V. Cutting edge: human CD4+CD25+T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol 2004, 172(April (8)):4676-4680.
55. Crispe I.N. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003, 3(January (1)):51-62.
56. Kasahara S., Ando K., Saito K., Sekikawa K., Ito H., Ishikawa T., et al. Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes. J Virol 2003, 77(February (4)):2469-2476.
57. Lan R.Y., Cheng C., Lian Z.X., Tsuneyama K., Yang G.X., Moritoki Y., et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 2006, 43(April (4)):729-737.
58. Lau G.K., Suri D., Liang R., Rigopoulou E.I., Thomas M.G., Mullerova I., et al. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology 2002, 122(March (3)):614-624.
59. Bauer T., Gunther M., Bienzle U., Neuhaus R., Jilg W. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells. Liver Transpl 2007, 13(March (3)):434-442.
60. Suvas S., Kumaraguru U., Pack C.D., Lee S., Rouse B.T. CD4+CD25+T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 2003, 198(September (6)):889-901.
61. Mao C., Wang S., Jiang Q., Tong J., Ma J., Yang M., et al. Increased CD4CD25+FOXP3+ regulatory T Cells in cancer patients from conversion of CD4+CD25-T cells through tumor-derived factors. Onkologie 2008, 31(May (5)):243-248.